KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Gains from Investment Securities (2017 - 2025)

Guardant Health's Gains from Investment Securities history spans 9 years, with the latest figure at $254000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 98.52% year-over-year to $254000.0; the TTM value through Dec 2025 reached $869000.0, down 94.46%, while the annual FY2025 figure was $869000.0, 94.46% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $254000.0 at Guardant Health, down from $335000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $83.6 million in Q4 2021 and bottomed at -$74.8 million in Q3 2021.
  • The 5-year median for Gains from Investment Securities is $1.4 million (2022), against an average of $5.8 million.
  • The largest annual shift saw Gains from Investment Securities surged 953.81% in 2021 before it crashed 2676.99% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $83.6 million in 2021, then tumbled by 98.37% to $1.4 million in 2022, then skyrocketed by 69.46% to $2.3 million in 2023, then soared by 645.68% to $17.2 million in 2024, then plummeted by 98.52% to $254000.0 in 2025.
  • Per Business Quant, the three most recent readings for GH's Gains from Investment Securities are $254000.0 (Q4 2025), $335000.0 (Q3 2025), and -$15.2 million (Q2 2025).